You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

extraocular extension melanoma

Showing 1 - 25 of 6,435
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Melanoma Trial in China (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Malignant Melanoma
  • Pembrolizumab
  • +2 more
  • Beijing, Beijing, China
  • +10 more
Dec 22, 2021

Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)

Completed
  • Intraocular Melanoma
  • +2 more
  • Santa Monica, California
  • +11 more
Jun 15, 2021

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant L-IFN adenovirus injection
  • Shanghai, Shanghai, China
    Shanghai Fengxian District Central Hospital
Jan 16, 2022

Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +16 more
Jun 2, 2023

Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Mucosal Melanoma Trial in United States (Laboratory Biomarker

Completed
Has Results
  • Iris Melanoma
  • +19 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +147 more
Jun 24, 2020

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,

Completed
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +10 more
  • cediranib maleate
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 27, 2018

Metastatic Melanoma Trial in Los Angeles (sunitinib malate, temozolomide)

Completed
  • Metastatic Melanoma
  • Los Angeles, California
    University of California Los Angeles (UCLA)
Jul 30, 2020

Quality of Life and Physical Fitness After Immune Checkpoint

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
    • Groningen, Netherlands
      University Medical Center Groningen
    Jan 3, 2023

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Melanoma, Cancer Survivorship Trial (Harvest for Health Together Arizona)

    Not yet recruiting
    • Melanoma
    • Cancer Survivorship
    • Harvest for Health Together Arizona
    • (no location specified)
    Dec 8, 2022

    Malignant Melanoma Stage III Trial in Worldwide (Ipilimumab, Nivolumab, Surgery)

    Active, not recruiting
    • Malignant Melanoma Stage III
    • Sydney, New South Wales, Australia
    • +3 more
    Apr 14, 2022

    Extraocular Extension Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma Trial in Buffalo (axitinib,

    Terminated
    Has Results
    • Extraocular Extension Melanoma
    • +11 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    May 8, 2018

    Advanced Malignant Tumors(Stage IA-IB) Trial in Beijing (AK129 IV infusion)

    Not yet recruiting
    • Advanced Malignant Tumors(Stage IA-IB)
    • AK129 IV infusion
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Science
    Jan 17, 2023

    Strabismus, Comitant Trial in Madrid (Extraocular muscle stretching)

    Active, not recruiting
    • Strabismus, Comitant
    • Extraocular muscle stretching
    • Madrid, Spain
      UAM
    Mar 9, 2023

    Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

    Completed
    Has Results
    • Unresectable Stage IIIB-IV Malignant Melanoma
    • Talimogene laherparepvec
    • Nagoya-shi, Aichi, Japan
    • +8 more
    Jan 13, 2023

    Cancer Trial in United States (SRK-181, anti-PD-(L)1 antibody therapy)

    Recruiting
    • Cancer
    • SRK-181
    • anti-PD-(L)1 antibody therapy
    • Fullerton, California
    • +13 more
    Jan 6, 2023

    Advanced Melanoma Trial in Beijing (JS001+Imatinib mesylate)

    Recruiting
    • Advanced Melanoma
    • JS001+Imatinib mesylate
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Mar 2, 2022

    Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Metastatic Melanoma
    • Stage IV Cutaneous Melanoma AJCC v6 and v7
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Choroidal Melanoma Trial in Aurora (1000CsK Silicon Oil Tamponade)

    Completed
    • Choroidal Melanoma
    • 1000CsK Silicon Oil Tamponade
    • Aurora, Colorado
      University of Colorado Eye Center
    Mar 4, 2022

    Psychoeducation for Uveal Melanoma

    Not yet recruiting
    • Uveal Melanoma
    • Education for Intervention
    • Best Practice
    • (no location specified)
    Oct 4, 2023

    Acquired Esotropia Trial in France, Switzerland (Botulinum toxin type A, Strabismus surgery)

    Active, not recruiting
    • Acquired Esotropia
    • Botulinum toxin type A
    • Strabismus surgery
    • Saint-Herblain, France
    • +7 more
    Mar 25, 2022

    Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

    Enrolling by invitation
    • Malignant Melanomas
    • Recombinant Human Adenovirus Type 5 Injection
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
    Jul 7, 2023

    Melanoma Trial in United States (CMP-001, Pembrolizumab)

    Active, not recruiting
    • Melanoma
    • Phoenix, Arizona
    • +12 more
    Aug 1, 2022